NICE initially recommends Jetrea for vitreomacular traction

Jetrea has received a provisional recommendation from the National Institute for Health and Care Excellence in the United Kingdom as an option for treating vitreomacular traction in adults, according to a news release.The next step involves formal consultation and comments as well as public input before NICE rules on whether Jetrea (ocriplasmin, ThromboGenics) can be approved for reimbursement within the National Health Service.

Full Story →